PubMed:29794029
Annnotations
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 157-351 | DRI_Approach | denotes | Active matrix metalloproteases (MMPs) play a significant role in the pathogenesis of many diseases including osteoarthritis (OA), which involves progressive proteolytic degradation of cartilage. |
T2 | 352-518 | DRI_Outcome | denotes | Clinical success of OA interventions that target MMPs has been limited by a lack of information about the presence and activity of specific disease-related proteases. |
T3 | 519-710 | DRI_Approach | denotes | We therefore developed a chemoproteomics approach based on MS to characterize the release and activity of MMPs in an in vitro model of the early inflammatory phase of posttraumatic OA (PTOA). |
T4 | 711-901 | DRI_Approach | denotes | We designed and synthesized chemical activity-based probes (ABPs) to identify active MMPs in bovine cartilage explants cultured for 30 days with the proinflammatory cytokine, interleukin-1α. |
T5 | 902-1280 | DRI_Approach | denotes | Using these probes in an activity-based protein profiling-multidimensional identification technology (ABPP-MudPIT) approach, we identified active MMP-1, -2, -3, -7, -9, -12, and -13 in the medium after 10 days of culture, the time at which irreversible proteolysis of the collagen network in the explant was detected using proteolytic activation of FRET-quenched MMP substrates. |
T6 | 1281-1449 | DRI_Background | denotes | Total MMP levels were quantified by shotgun proteomics, which, taken with ABPP-MudPIT data, indicated the presence of predominantly inactive MMPs in the culture medium. |
T7 | 1450-1610 | DRI_Outcome | denotes | The selectivity of the ABPP-MudPIT approach was further validated by detection of specific endogenous MMPs activated de novo with 4-aminophenylmurcuric acetate. |
T8 | 1611-1828 | DRI_Challenge | denotes | The utility of the new ABPP-MudPIT approach for detecting molecular biomarkers of PTOA disease initiation and potential targets for therapeutics motivates possible application in other diseases involving MMP activity. |
Goldhamster2_Cellosaurus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 46-47 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T2 | 157-163 | CVCL_C410|Hybridoma|Mus musculus | denotes | Active |
T3 | 200-201 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T4 | 406-409 | CVCL_6758|Undefined_cell_line_type|Cricetulus griseus | denotes | has |
T5 | 406-409 | CVCL_E689|Transformed_cell_line|Homo sapiens | denotes | has |
T6 | 426-427 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T7 | 471-479 | CVCL_C410|Hybridoma|Mus musculus | denotes | activity |
T8 | 519-521 | CVCL_5M23|Cancer_cell_line|Mesocricetus auratus | denotes | We |
T9 | 542-543 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |
T10 | 613-621 | CVCL_C410|Hybridoma|Mus musculus | denotes | activity |
T11 | 633-635 | CVCL_8754|Cancer_cell_line|Homo sapiens | denotes | an |
T12 | 633-635 | CVCL_H241|Cancer_cell_line|Homo sapiens | denotes | an |
T13 | 711-713 | CVCL_5M23|Cancer_cell_line|Mesocricetus auratus | denotes | We |
T14 | 748-756 | CVCL_C410|Hybridoma|Mus musculus | denotes | activity |
T15 | 789-795 | CVCL_C410|Hybridoma|Mus musculus | denotes | active |
T16 | 843-845 | CVCL_J925|Hybridoma|Mus musculus | denotes | 30 |
T17 | 924-926 | CVCL_8754|Cancer_cell_line|Homo sapiens | denotes | an |
T18 | 924-926 | CVCL_H241|Cancer_cell_line|Homo sapiens | denotes | an |
T19 | 927-935 | CVCL_C410|Hybridoma|Mus musculus | denotes | activity |
T20 | 1027-1029 | CVCL_5M23|Cancer_cell_line|Mesocricetus auratus | denotes | we |
T21 | 1041-1047 | CVCL_C410|Hybridoma|Mus musculus | denotes | active |
T22 | 1052-1061 | CVCL_HE67|Factor-dependent_cell_line|Mus musculus | denotes | 1, -2, -3 |
T23 | 1128-1132 | CVCL_0047|Telomerase_immortalized_cell_line|Homo sapiens | denotes | time |
T24 | 1237-1247 | CVCL_C410|Hybridoma|Mus musculus | denotes | activation |
T25 | 1557-1566 | CVCL_C410|Hybridoma|Mus musculus | denotes | activated |
T26 | 1819-1827 | CVCL_C410|Hybridoma|Mus musculus | denotes | activity |
GoldHamster
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 19-25 | UBERON:0027368 | denotes | matrix |
T2 | 26-42 | D045726 | denotes | metalloproteases |
T3 | 57-66 | UBERON:0002418 | denotes | cartilage |
T4 | 57-66 | UBERON:0007844 | denotes | cartilage |
T5 | 100-110 | D015415 | denotes | biomarkers |
T6 | 100-110 | D015415 | denotes | biomarkers |
T7 | 141-155 | D010003 | denotes | osteoarthritis |
T8 | 141-155 | D010003 | denotes | osteoarthritis |
T9 | 164-170 | UBERON:0027368 | denotes | matrix |
T10 | 171-187 | D045726 | denotes | metalloproteases |
T11 | 189-193 | D020782 | denotes | MMPs |
T12 | 226-238 | GO:0009405 | denotes | pathogenesis |
T13 | 266-280 | D010003 | denotes | osteoarthritis |
T14 | 266-280 | D010003 | denotes | osteoarthritis |
T15 | 326-337 | GO:0009056 | denotes | degradation |
T16 | 341-350 | UBERON:0002418 | denotes | cartilage |
T17 | 341-350 | UBERON:0007844 | denotes | cartilage |
T18 | 401-405 | D020782 | denotes | MMPs |
T19 | 428-432 | PR:Q9V853 | denotes | lack |
T20 | 492-499 | D004194 | denotes | disease |
T21 | 492-499 | D004194 | denotes | disease |
T22 | 508-517 | D010447 | denotes | proteases |
T23 | 625-629 | D020782 | denotes | MMPs |
T24 | 796-800 | D020782 | denotes | MMPs |
T25 | 804-810 | 9913 | denotes | bovine |
T26 | 811-820 | UBERON:0002418 | denotes | cartilage |
T27 | 811-820 | UBERON:0007844 | denotes | cartilage |
T31 | 886-899 | PR:000001091 | denotes | interleukin-1 |
T30 | 886-899 | D007375 | denotes | interleukin-1 |
T32 | 886-899 | D007375 | denotes | interleukin-1 |
T37 | 942-949 | SO:0000104 | denotes | protein |
T36 | 942-949 | PR:000000001 | denotes | protein |
T33 | 942-949 | GO:0003675 | denotes | protein |
T34 | 942-949 | CHEBI:36080 | denotes | protein |
T35 | 942-949 | CHEBI:11122 | denotes | protein |
T38 | 1004-1008 | P08592 | denotes | ABPP |
T39 | 1004-1008 | O93279 | denotes | ABPP |
T40 | 1004-1008 | Q28748 | denotes | ABPP |
T41 | 1004-1008 | Q60495 | denotes | ABPP |
T42 | 1004-1008 | P12023 | denotes | ABPP |
T43 | 1004-1008 | Q28757 | denotes | ABPP |
T44 | 1004-1008 | O73683 | denotes | ABPP |
T45 | 1004-1008 | Q95241 | denotes | ABPP |
T46 | 1004-1008 | P05067 | denotes | ABPP |
T47 | 1004-1008 | PR:000004168 | denotes | ABPP |
T48 | 1004-1008 | Q29149 | denotes | ABPP |
T49 | 1004-1008 | P79307 | denotes | ABPP |
T50 | 1004-1008 | P29216 | denotes | ABPP |
T51 | 1004-1008 | P86906 | denotes | ABPP |
T52 | 1004-1008 | Q28280 | denotes | ABPP |
T53 | 1004-1008 | Q28053 | denotes | ABPP |
T54 | 1004-1008 | Q5IS80 | denotes | ABPP |
T55 | 1004-1008 | P53601 | denotes | ABPP |
T56 | 1048-1051 | CHEBI:340824 | denotes | MMP |
T59 | 1048-1051 | CHEBI:59761 | denotes | MMP |
T61 | 1048-1053 | Q11133 | denotes | MMP-1 |
T62 | 1048-1053 | P13943 | denotes | MMP-1 |
T63 | 1048-1053 | PR:P03956 | denotes | MMP-1 |
T64 | 1048-1053 | P21692 | denotes | MMP-1 |
T65 | 1048-1053 | PR:Q8GWW6 | denotes | MMP-1 |
T66 | 1048-1053 | P81563 | denotes | MMP-1 |
T67 | 1048-1053 | PR:000010469 | denotes | MMP-1 |
T68 | 1048-1053 | Q9XSZ5 | denotes | MMP-1 |
T69 | 1048-1053 | P28053 | denotes | MMP-1 |
T70 | 1048-1053 | PR:Q12372 | denotes | MMP-1 |
T71 | 1048-1053 | P03956 | denotes | MMP-1 |
T60 | 1048-1053 | GO:0004232 | denotes | MMP-1 |
T72 | 1155-1166 | GO:0006508 | denotes | proteolysis |
T74 | 1174-1182 | 2714 | denotes | collagen |
T75 | 1174-1182 | D003094 | denotes | collagen |
T76 | 1174-1182 | CHEBI:3815 | denotes | collagen |
T73 | 1174-1182 | GO:0005202 | denotes | collagen |
T77 | 1174-1190 | GO:0098645 | denotes | collagen network |
T80 | 1265-1268 | PR:O04529 | denotes | MMP |
T78 | 1265-1268 | CHEBI:340824 | denotes | MMP |
T81 | 1265-1268 | CHEBI:59761 | denotes | MMP |
T79 | 1265-1268 | GO:0004235 | denotes | MMP |
T84 | 1287-1290 | PR:O04529 | denotes | MMP |
T82 | 1287-1290 | CHEBI:340824 | denotes | MMP |
T85 | 1287-1290 | CHEBI:59761 | denotes | MMP |
T83 | 1287-1290 | GO:0004235 | denotes | MMP |
T86 | 1355-1359 | P08592 | denotes | ABPP |
T87 | 1355-1359 | O93279 | denotes | ABPP |
T88 | 1355-1359 | Q28748 | denotes | ABPP |
T89 | 1355-1359 | Q60495 | denotes | ABPP |
T90 | 1355-1359 | P12023 | denotes | ABPP |
T91 | 1355-1359 | Q28757 | denotes | ABPP |
T92 | 1355-1359 | O73683 | denotes | ABPP |
T93 | 1355-1359 | Q95241 | denotes | ABPP |
T94 | 1355-1359 | P05067 | denotes | ABPP |
T95 | 1355-1359 | PR:000004168 | denotes | ABPP |
T96 | 1355-1359 | Q29149 | denotes | ABPP |
T97 | 1355-1359 | P79307 | denotes | ABPP |
T98 | 1355-1359 | P29216 | denotes | ABPP |
T99 | 1355-1359 | P86906 | denotes | ABPP |
T100 | 1355-1359 | Q28280 | denotes | ABPP |
T101 | 1355-1359 | Q28053 | denotes | ABPP |
T102 | 1355-1359 | Q5IS80 | denotes | ABPP |
T103 | 1355-1359 | P53601 | denotes | ABPP |
T104 | 1422-1426 | D020782 | denotes | MMPs |
T105 | 1473-1477 | P08592 | denotes | ABPP |
T106 | 1473-1477 | O93279 | denotes | ABPP |
T107 | 1473-1477 | Q28748 | denotes | ABPP |
T108 | 1473-1477 | Q60495 | denotes | ABPP |
T109 | 1473-1477 | P12023 | denotes | ABPP |
T110 | 1473-1477 | Q28757 | denotes | ABPP |
T111 | 1473-1477 | O73683 | denotes | ABPP |
T112 | 1473-1477 | Q95241 | denotes | ABPP |
T113 | 1473-1477 | P05067 | denotes | ABPP |
T114 | 1473-1477 | PR:000004168 | denotes | ABPP |
T115 | 1473-1477 | Q29149 | denotes | ABPP |
T116 | 1473-1477 | P79307 | denotes | ABPP |
T117 | 1473-1477 | P29216 | denotes | ABPP |
T118 | 1473-1477 | P86906 | denotes | ABPP |
T119 | 1473-1477 | Q28280 | denotes | ABPP |
T120 | 1473-1477 | Q28053 | denotes | ABPP |
T121 | 1473-1477 | Q5IS80 | denotes | ABPP |
T122 | 1473-1477 | P53601 | denotes | ABPP |
T123 | 1506-1515 | SO:0000789 | denotes | validated |
T124 | 1552-1556 | D020782 | denotes | MMPs |
T125 | 1602-1609 | CHEBI:47622 | denotes | acetate |
T127 | 1602-1609 | CHEBI:30089 | denotes | acetate |
T126 | 1602-1609 | 164 | denotes | acetate |
T128 | 1634-1638 | P08592 | denotes | ABPP |
T129 | 1634-1638 | O93279 | denotes | ABPP |
T130 | 1634-1638 | Q28748 | denotes | ABPP |
T131 | 1634-1638 | Q60495 | denotes | ABPP |
T132 | 1634-1638 | P12023 | denotes | ABPP |
T133 | 1634-1638 | Q28757 | denotes | ABPP |
T134 | 1634-1638 | O73683 | denotes | ABPP |
T135 | 1634-1638 | Q95241 | denotes | ABPP |
T136 | 1634-1638 | P05067 | denotes | ABPP |
T137 | 1634-1638 | PR:000004168 | denotes | ABPP |
T138 | 1634-1638 | Q29149 | denotes | ABPP |
T139 | 1634-1638 | P79307 | denotes | ABPP |
T140 | 1634-1638 | P29216 | denotes | ABPP |
T141 | 1634-1638 | P86906 | denotes | ABPP |
T142 | 1634-1638 | Q28280 | denotes | ABPP |
T143 | 1634-1638 | Q28053 | denotes | ABPP |
T144 | 1634-1638 | Q5IS80 | denotes | ABPP |
T145 | 1634-1638 | P53601 | denotes | ABPP |
T146 | 1679-1689 | D015415 | denotes | biomarkers |
T147 | 1679-1689 | D015415 | denotes | biomarkers |
T148 | 1698-1705 | D004194 | denotes | disease |
T149 | 1698-1705 | D004194 | denotes | disease |
T152 | 1815-1818 | PR:O04529 | denotes | MMP |
T150 | 1815-1818 | CHEBI:340824 | denotes | MMP |
T153 | 1815-1818 | CHEBI:59761 | denotes | MMP |
T151 | 1815-1818 | GO:0004235 | denotes | MMP |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-156 | Sentence | denotes | Chemoproteomics of matrix metalloproteases in a model of cartilage degeneration suggests functional biomarkers associated with posttraumatic osteoarthritis. |
T2 | 157-351 | Sentence | denotes | Active matrix metalloproteases (MMPs) play a significant role in the pathogenesis of many diseases including osteoarthritis (OA), which involves progressive proteolytic degradation of cartilage. |
T3 | 352-518 | Sentence | denotes | Clinical success of OA interventions that target MMPs has been limited by a lack of information about the presence and activity of specific disease-related proteases. |
T4 | 519-710 | Sentence | denotes | We therefore developed a chemoproteomics approach based on MS to characterize the release and activity of MMPs in an in vitro model of the early inflammatory phase of posttraumatic OA (PTOA). |
T5 | 711-901 | Sentence | denotes | We designed and synthesized chemical activity-based probes (ABPs) to identify active MMPs in bovine cartilage explants cultured for 30 days with the proinflammatory cytokine, interleukin-1α. |
T6 | 902-1280 | Sentence | denotes | Using these probes in an activity-based protein profiling-multidimensional identification technology (ABPP-MudPIT) approach, we identified active MMP-1, -2, -3, -7, -9, -12, and -13 in the medium after 10 days of culture, the time at which irreversible proteolysis of the collagen network in the explant was detected using proteolytic activation of FRET-quenched MMP substrates. |
T7 | 1281-1449 | Sentence | denotes | Total MMP levels were quantified by shotgun proteomics, which, taken with ABPP-MudPIT data, indicated the presence of predominantly inactive MMPs in the culture medium. |
T8 | 1450-1610 | Sentence | denotes | The selectivity of the ABPP-MudPIT approach was further validated by detection of specific endogenous MMPs activated de novo with 4-aminophenylmurcuric acetate. |
T9 | 1611-1828 | Sentence | denotes | The utility of the new ABPP-MudPIT approach for detecting molecular biomarkers of PTOA disease initiation and potential targets for therapeutics motivates possible application in other diseases involving MMP activity. |
T1 | 0-156 | Sentence | denotes | Chemoproteomics of matrix metalloproteases in a model of cartilage degeneration suggests functional biomarkers associated with posttraumatic osteoarthritis. |
T2 | 157-351 | Sentence | denotes | Active matrix metalloproteases (MMPs) play a significant role in the pathogenesis of many diseases including osteoarthritis (OA), which involves progressive proteolytic degradation of cartilage. |
T3 | 352-518 | Sentence | denotes | Clinical success of OA interventions that target MMPs has been limited by a lack of information about the presence and activity of specific disease-related proteases. |
T4 | 519-710 | Sentence | denotes | We therefore developed a chemoproteomics approach based on MS to characterize the release and activity of MMPs in an in vitro model of the early inflammatory phase of posttraumatic OA (PTOA). |
T5 | 711-901 | Sentence | denotes | We designed and synthesized chemical activity-based probes (ABPs) to identify active MMPs in bovine cartilage explants cultured for 30 days with the proinflammatory cytokine, interleukin-1α. |
T6 | 902-1280 | Sentence | denotes | Using these probes in an activity-based protein profiling-multidimensional identification technology (ABPP-MudPIT) approach, we identified active MMP-1, -2, -3, -7, -9, -12, and -13 in the medium after 10 days of culture, the time at which irreversible proteolysis of the collagen network in the explant was detected using proteolytic activation of FRET-quenched MMP substrates. |
T7 | 1281-1449 | Sentence | denotes | Total MMP levels were quantified by shotgun proteomics, which, taken with ABPP-MudPIT data, indicated the presence of predominantly inactive MMPs in the culture medium. |
T8 | 1450-1610 | Sentence | denotes | The selectivity of the ABPP-MudPIT approach was further validated by detection of specific endogenous MMPs activated de novo with 4-aminophenylmurcuric acetate. |
T9 | 1611-1828 | Sentence | denotes | The utility of the new ABPP-MudPIT approach for detecting molecular biomarkers of PTOA disease initiation and potential targets for therapeutics motivates possible application in other diseases involving MMP activity. |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-156 | Sentence | denotes | Chemoproteomics of matrix metalloproteases in a model of cartilage degeneration suggests functional biomarkers associated with posttraumatic osteoarthritis. |
T2 | 157-351 | Sentence | denotes | Active matrix metalloproteases (MMPs) play a significant role in the pathogenesis of many diseases including osteoarthritis (OA), which involves progressive proteolytic degradation of cartilage. |
T3 | 352-518 | Sentence | denotes | Clinical success of OA interventions that target MMPs has been limited by a lack of information about the presence and activity of specific disease-related proteases. |
T4 | 519-710 | Sentence | denotes | We therefore developed a chemoproteomics approach based on MS to characterize the release and activity of MMPs in an in vitro model of the early inflammatory phase of posttraumatic OA (PTOA). |
T5 | 711-901 | Sentence | denotes | We designed and synthesized chemical activity-based probes (ABPs) to identify active MMPs in bovine cartilage explants cultured for 30 days with the proinflammatory cytokine, interleukin-1α. |
T6 | 902-1280 | Sentence | denotes | Using these probes in an activity-based protein profiling-multidimensional identification technology (ABPP-MudPIT) approach, we identified active MMP-1, -2, -3, -7, -9, -12, and -13 in the medium after 10 days of culture, the time at which irreversible proteolysis of the collagen network in the explant was detected using proteolytic activation of FRET-quenched MMP substrates. |
T7 | 1281-1449 | Sentence | denotes | Total MMP levels were quantified by shotgun proteomics, which, taken with ABPP-MudPIT data, indicated the presence of predominantly inactive MMPs in the culture medium. |
T8 | 1450-1610 | Sentence | denotes | The selectivity of the ABPP-MudPIT approach was further validated by detection of specific endogenous MMPs activated de novo with 4-aminophenylmurcuric acetate. |
T9 | 1611-1828 | Sentence | denotes | The utility of the new ABPP-MudPIT approach for detecting molecular biomarkers of PTOA disease initiation and potential targets for therapeutics motivates possible application in other diseases involving MMP activity. |
Glycosmos6-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 57-66 | http://purl.obolibrary.org/obo/MAT_0000189 | denotes | cartilage |
T2 | 341-350 | http://purl.obolibrary.org/obo/MAT_0000189 | denotes | cartilage |
T3 | 811-820 | http://purl.obolibrary.org/obo/MAT_0000189 | denotes | cartilage |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 141-155 | Phenotype | denotes | osteoarthritis | HP:0002758 |
T2 | 266-280 | Phenotype | denotes | osteoarthritis | HP:0002758 |
T3 | 282-284 | Phenotype | denotes | OA | HP:0002758 |
T4 | 372-374 | Phenotype | denotes | OA | HP:0002758 |
T5 | 700-702 | Phenotype | denotes | OA | HP:0002758 |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 141-155 | Disease | denotes | osteoarthritis | http://purl.obolibrary.org/obo/MONDO_0005178 |
T2 | 266-280 | Disease | denotes | osteoarthritis | http://purl.obolibrary.org/obo/MONDO_0005178 |
T3 | 282-284 | Disease | denotes | OA | http://purl.obolibrary.org/obo/MONDO_0005178 |
T4 | 372-374 | Disease | denotes | OA | http://purl.obolibrary.org/obo/MONDO_0005178 |
T5 | 700-702 | Disease | denotes | OA | http://purl.obolibrary.org/obo/MONDO_0005178 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 804-810 | OrganismTaxon | denotes | bovine | 9913 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 57-66 | Body_part | denotes | cartilage | http://purl.obolibrary.org/obo/UBERON_0002418|http://purl.obolibrary.org/obo/UBERON_0007844 |
T3 | 341-350 | Body_part | denotes | cartilage | http://purl.obolibrary.org/obo/UBERON_0002418|http://purl.obolibrary.org/obo/UBERON_0007844 |
T5 | 811-820 | Body_part | denotes | cartilage | http://purl.obolibrary.org/obo/UBERON_0002418|http://purl.obolibrary.org/obo/UBERON_0007844 |
T7 | 1174-1190 | Body_part | denotes | collagen network | http://purl.obolibrary.org/obo/GO_0098645 |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 57-66 | Body_part | denotes | cartilage | http://purl.obolibrary.org/obo/MAT_0000189 |
T2 | 341-350 | Body_part | denotes | cartilage | http://purl.obolibrary.org/obo/MAT_0000189 |
T3 | 811-820 | Body_part | denotes | cartilage | http://purl.obolibrary.org/obo/MAT_0000189 |